22 Nov 2016
(MENAFN) UAE-based Julphar Gulf Pharmaceutical Industries has reported sales revenue of USD290.2mn in the Jan-Sep period of this year.
Furthermore, the firm posted gross revenue of USD169.5mn and its net profit for the period was USD42.8mn.
Accordingly, the Saudi and UAE markets contributed 56 percent of the sales for the cited period, while the growth in the MENA markets has been slow for the period.
In recent challenging environment, the firm’s management has taken steps to reduce cost, like Opex Control to enhance profitability.
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
26 Jan 2026
BBK Enhances Autumn Fair 2026 Experience with Customized Rewards and Premium Services
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more